Andalusia Launches Herpes Zoster Vaccination Campaign: What You Need to Know
The Andalusian Health Service (SAS) is rolling out a vaccination campaign against herpes zoster, commonly known as shingles, targeting individuals born between 1959 and 1961. This initiative aims to protect a population aged 65 to 67 from the potentially severe complications associated with the reactivation of this virus.
Understanding Herpes Zoster: The ‘Culebrina’
Herpes zoster is caused by the varicella-zoster virus – the same virus that causes chickenpox. After a chickenpox infection, the virus remains dormant in the nervous system. As explained by Dr. Leandro Martínez, Head of Dermatology at the Regional Hospital of Málaga, the virus doesn’t disappear after chickenpox; it lies “dormant or latent” within the nervous system, potentially reactivating later in life.
The risk of reactivation increases with age or when the body’s defenses are weakened. The campaign focuses on those born between 1959 and 1961, as the number of complications related to the virus increases from these ages.
Symptoms and Complications Beyond the Rash
When the virus reactivates, it travels along nerve pathways to the skin, causing a characteristic rash with blisters, known as a dermatome. This rash typically affects a specific area of the body. However, the most debilitating symptom is often intense pain and a burning sensation accompanying the lesions.
Complications can extend beyond the skin. The most feared is postherpetic neuralgia, a chronic and severe pain that can persist for months or even years after the rash has healed. If the virus affects the facial area, it can lead to facial paralysis. Herpes zoster ophthalmicus, affecting the eye, poses a risk to vision.
Vaccination: A Powerful Preventative Measure
Vaccination is considered the most effective way to prevent both the reactivation of the virus and its complications. Dr. Martínez emphasizes that the vaccine “reinforces specific immunity against this varicella-zoster virus and significantly reduces the risk of developing herpes zoster and, above all, its complications.”
The current campaign prioritizes individuals over 65, as the immune system naturally weakens with age – a process known as immunosenescence. However, vaccination is also recommended for those aged 50 to 65 with chronic illnesses or those undergoing treatments that compromise their immune systems.
Campaign Details in Málaga and Beyond
In Málaga, vaccinations are being offered to those born in 1959, 1960, and 1961 at health centers within the Málaga-Valle del Guadalhorce Health District. Appointments are available on Tuesdays and Thursdays from 5:00 PM to 7:30 PM. The Junta de Andalucía is expanding vaccination access to those aged 65 (born in 1961) as of May 20, 2024, and is also offering a “rescue” program for those aged 66 and 67 (born in 1959 and 1960) who haven’t completed the two-dose vaccination schedule.
Frequently Asked Questions
- Who is eligible for the herpes zoster vaccine in Andalusia? Individuals born between 1959 and 1961 are currently eligible, with priority given to those aged 65 and over.
- What are the potential complications of herpes zoster? Postherpetic neuralgia (chronic pain), facial paralysis, and vision problems are potential complications.
- Where can I get vaccinated? Vaccinations are available at health centers within designated health districts.
- Is the vaccine effective? The vaccine can prevent herpes zoster in over 97% of cases and reduce the risk of complications.
Pro Tip: Even if you’ve had chickenpox, you are still at risk of developing herpes zoster later in life. Vaccination is the best way to protect yourself.
Stay informed about the latest health updates and vaccination campaigns in Andalusia by visiting the Junta de Andalucía Health Service website.
